The global market for Preclinical Toxicology Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Preclinical Toxicology Testing Services are a set of laboratory and research services conducted to assess the safety and potential toxicity of new drugs, chemicals, medical devices, or other substances before they are tested in humans in clinical trials. These services are an essential part of the drug development and regulatory approval process and are typically required by regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure the safety and efficacy of new pharmaceutical and chemical compounds.
The global preclinical toxicology testing services market is significant and has experienced steady growth in recent years. It is driven by the continuous development of new pharmaceuticals, chemicals, and medical devices, as well as increasing regulatory scrutiny. The United States is a major hub for preclinical toxicology testing services, with a well-established pharmaceutical and biotechnology industry. Regulatory requirements from the FDA drive the demand for toxicology testing. Countries within the European Union also have significant demand for preclinical toxicology testing due to the robust pharmaceutical industry. Regulatory bodies like the European Medicines Agency (EMA) require safety assessments for market approval. The Asia-Pacific region is experiencing substantial growth in preclinical toxicology testing services, particularly in countries like China and India, where the pharmaceutical and chemical industries are expanding rapidly.
This report aims to provide a comprehensive presentation of the global market for Preclinical Toxicology Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Toxicology Testing Service.
The Preclinical Toxicology Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical Toxicology Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Toxicology Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Agilent
Abbott
Bio-Rad
Scantox
Charles River
Bioreliance
Catalent
INVITEK Inc.
Altogen Labs
Pacific BioLabs
AmplifyBio
Altasciences
Evotec
Eurofins Scientific
Pharmaron
Segment by Type
In Vitro Toxicology Testing
In Vivo Toxicology Testing
Segment by Application
Biopharmaceutical Company
Research Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Toxicology Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Preclinical Toxicology Testing Service 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vitro Toxicology Testing
1.2.3 In Vivo Toxicology Testing
1.3 麻豆原创 by Application
1.3.1 Global Preclinical Toxicology Testing Service 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Company
1.3.3 Research Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Toxicology Testing Service 麻豆原创 Perspective (2020-2031)
2.2 Global Preclinical Toxicology Testing Service Growth Trends by Region
2.2.1 Global Preclinical Toxicology Testing Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preclinical Toxicology Testing Service Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Preclinical Toxicology Testing Service Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Preclinical Toxicology Testing Service 麻豆原创 Dynamics
2.3.1 Preclinical Toxicology Testing Service Industry Trends
2.3.2 Preclinical Toxicology Testing Service 麻豆原创 Drivers
2.3.3 Preclinical Toxicology Testing Service 麻豆原创 Challenges
2.3.4 Preclinical Toxicology Testing Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Toxicology Testing Service Players by Revenue
3.1.1 Global Top Preclinical Toxicology Testing Service Players by Revenue (2020-2025)
3.1.2 Global Preclinical Toxicology Testing Service Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Preclinical Toxicology Testing Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preclinical Toxicology Testing Service Revenue
3.4 Global Preclinical Toxicology Testing Service 麻豆原创 Concentration Ratio
3.4.1 Global Preclinical Toxicology Testing Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Toxicology Testing Service Revenue in 2024
3.5 Global Key Players of Preclinical Toxicology Testing Service Head office and Area Served
3.6 Global Key Players of Preclinical Toxicology Testing Service, Product and Application
3.7 Global Key Players of Preclinical Toxicology Testing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Toxicology Testing Service Breakdown Data by Type
4.1 Global Preclinical Toxicology Testing Service Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Preclinical Toxicology Testing Service Forecasted 麻豆原创 Size by Type (2026-2031)
5 Preclinical Toxicology Testing Service Breakdown Data by Application
5.1 Global Preclinical Toxicology Testing Service Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Preclinical Toxicology Testing Service Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Preclinical Toxicology Testing Service 麻豆原创 Size (2020-2031)
6.2 North America Preclinical Toxicology Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2020-2025)
6.4 North America Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Toxicology Testing Service 麻豆原创 Size (2020-2031)
7.2 Europe Preclinical Toxicology Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2020-2025)
7.4 Europe Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Toxicology Testing Service 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Preclinical Toxicology Testing Service 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preclinical Toxicology Testing Service 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Preclinical Toxicology Testing Service 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Toxicology Testing Service 麻豆原创 Size (2020-2031)
9.2 Latin America Preclinical Toxicology Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Preclinical Toxicology Testing Service Introduction
11.1.4 Agilent Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.1.5 Agilent Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Preclinical Toxicology Testing Service Introduction
11.2.4 Abbott Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Preclinical Toxicology Testing Service Introduction
11.3.4 Bio-Rad Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.3.5 Bio-Rad Recent Development
11.4 Scantox
11.4.1 Scantox Company Details
11.4.2 Scantox Business Overview
11.4.3 Scantox Preclinical Toxicology Testing Service Introduction
11.4.4 Scantox Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.4.5 Scantox Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Preclinical Toxicology Testing Service Introduction
11.5.4 Charles River Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.5.5 Charles River Recent Development
11.6 Bioreliance
11.6.1 Bioreliance Company Details
11.6.2 Bioreliance Business Overview
11.6.3 Bioreliance Preclinical Toxicology Testing Service Introduction
11.6.4 Bioreliance Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.6.5 Bioreliance Recent Development
11.7 Catalent
11.7.1 Catalent Company Details
11.7.2 Catalent Business Overview
11.7.3 Catalent Preclinical Toxicology Testing Service Introduction
11.7.4 Catalent Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.7.5 Catalent Recent Development
11.8 INVITEK Inc.
11.8.1 INVITEK Inc. Company Details
11.8.2 INVITEK Inc. Business Overview
11.8.3 INVITEK Inc. Preclinical Toxicology Testing Service Introduction
11.8.4 INVITEK Inc. Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.8.5 INVITEK Inc. Recent Development
11.9 Altogen Labs
11.9.1 Altogen Labs Company Details
11.9.2 Altogen Labs Business Overview
11.9.3 Altogen Labs Preclinical Toxicology Testing Service Introduction
11.9.4 Altogen Labs Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.9.5 Altogen Labs Recent Development
11.10 Pacific BioLabs
11.10.1 Pacific BioLabs Company Details
11.10.2 Pacific BioLabs Business Overview
11.10.3 Pacific BioLabs Preclinical Toxicology Testing Service Introduction
11.10.4 Pacific BioLabs Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.10.5 Pacific BioLabs Recent Development
11.11 AmplifyBio
11.11.1 AmplifyBio Company Details
11.11.2 AmplifyBio Business Overview
11.11.3 AmplifyBio Preclinical Toxicology Testing Service Introduction
11.11.4 AmplifyBio Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.11.5 AmplifyBio Recent Development
11.12 Altasciences
11.12.1 Altasciences Company Details
11.12.2 Altasciences Business Overview
11.12.3 Altasciences Preclinical Toxicology Testing Service Introduction
11.12.4 Altasciences Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.12.5 Altasciences Recent Development
11.13 Evotec
11.13.1 Evotec Company Details
11.13.2 Evotec Business Overview
11.13.3 Evotec Preclinical Toxicology Testing Service Introduction
11.13.4 Evotec Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.13.5 Evotec Recent Development
11.14 Eurofins Scientific
11.14.1 Eurofins Scientific Company Details
11.14.2 Eurofins Scientific Business Overview
11.14.3 Eurofins Scientific Preclinical Toxicology Testing Service Introduction
11.14.4 Eurofins Scientific Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.14.5 Eurofins Scientific Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Preclinical Toxicology Testing Service Introduction
11.15.4 Pharmaron Revenue in Preclinical Toxicology Testing Service Business (2020-2025)
11.15.5 Pharmaron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Agilent
Abbott
Bio-Rad
Scantox
Charles River
Bioreliance
Catalent
INVITEK Inc.
Altogen Labs
Pacific BioLabs
AmplifyBio
Altasciences
Evotec
Eurofins Scientific
Pharmaron
听
听
*If Applicable.
